Alkem Laboratories Limited (BOM:539523)
India · Delayed Price · Currency is INR 5,497.80
+45.55 (0.84%)
At close: May 29, 2026
Alkem Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 23,018 | 21,655 | 17,958 | 9,842 | 16,456 |
Depreciation & Amortization | 3,821 | 3,438 | 2,860 | 2,986 | 2,936 |
Other Amortization | - | 133.4 | 133.5 | 118.1 | 103.7 |
Loss (Gain) From Sale of Assets | -127.8 | -46 | 31.8 | 123.6 | 14.3 |
Asset Writedown & Restructuring Costs | - | 137.3 | 992.2 | 1,052 | 11.2 |
Loss (Gain) From Sale of Investments | -537.8 | -528.9 | -151.7 | -308.6 | 35.2 |
Stock-Based Compensation | 48.7 | 166.1 | 189.4 | - | - |
Provision & Write-off of Bad Debts | 737.7 | 133.7 | 524 | 48.8 | 27.8 |
Other Operating Activities | -3,177 | -3,821 | -2,539 | -303.9 | -3,025 |
Change in Accounts Receivable | -3,289 | -2,186 | -2,220 | -1,347 | -2,218 |
Change in Inventory | -2,473 | -2,612 | -734 | 4,734 | -6,731 |
Change in Accounts Payable | 1,214 | 2,167 | 5,253 | 145.1 | 3,345 |
Change in Other Net Operating Assets | 395.9 | 491.6 | -2,816 | -264.4 | 154.4 |
Operating Cash Flow | 19,630 | 19,128 | 19,481 | 16,825 | 11,110 |
Operating Cash Flow Growth | 2.62% | -1.81% | 15.78% | 51.44% | -12.16% |
Capital Expenditures | -6,173 | -6,756 | -2,593 | -2,329 | -3,389 |
Sale of Property, Plant & Equipment | 1,303 | 408.4 | 724.8 | 32 | 109 |
Cash Acquisitions | -2,054 | - | - | - | - |
Investment in Securities | -13,025 | -10,119 | -10,612 | 1,955 | -12,051 |
Other Investing Activities | 3,277 | 3,479 | 2,395 | 1,471 | 979.6 |
Investing Cash Flow | -16,672 | -12,988 | -10,085 | 1,128 | -14,351 |
Short-Term Debt Issued | 1,345 | - | - | - | 8,821 |
Long-Term Debt Issued | 1,795 | 2,879 | 400 | - | - |
Total Debt Issued | 3,140 | 2,879 | 400 | - | 8,821 |
Short-Term Debt Repaid | - | -4,820 | -5,209 | -12,690 | - |
Long-Term Debt Repaid | -1,064 | -316.5 | -323.2 | -333.4 | -404.6 |
Total Debt Repaid | -1,064 | -5,137 | -5,532 | -13,023 | -404.6 |
Net Debt Issued (Repaid) | 2,076 | -2,258 | -5,132 | -13,023 | 8,416 |
Common Dividends Paid | -6,137 | -5,022 | -5,380 | -2,272 | -4,185 |
Other Financing Activities | -972.7 | -830.6 | -937.6 | 675.9 | -435.6 |
Financing Cash Flow | -5,034 | -8,110 | -11,450 | -17,608 | 3,796 |
Foreign Exchange Rate Adjustments | -144.6 | 105.1 | -20.5 | 71 | 25 |
Net Cash Flow | -2,220 | -1,864 | -2,075 | 416.2 | 579.6 |
Free Cash Flow | 13,458 | 12,372 | 16,888 | 14,496 | 7,721 |
Free Cash Flow Growth | 8.77% | -26.74% | 16.50% | 87.74% | -27.84% |
Free Cash Flow Margin | 9.15% | 9.54% | 13.33% | 12.50% | 7.26% |
Free Cash Flow Per Share | 112.55 | 103.48 | 141.24 | 121.24 | 64.58 |
Cash Interest Paid | 1,235 | 806.1 | 913.1 | 904.6 | 401.3 |
Cash Income Tax Paid | 6,290 | 5,040 | 4,069 | 2,734 | 3,969 |
Levered Free Cash Flow | 13,743 | 6,353 | 30,973 | 5,554 | -6,087 |
Unlevered Free Cash Flow | 14,748 | 7,008 | 31,579 | 6,059 | -5,894 |
Change in Working Capital | -4,152 | -2,140 | -516.9 | 3,268 | -5,450 |